Skip to Main content Skip to Navigation
Journal articles

Vaccination against encapsulated bacteria in humans: paradoxes.

Abstract : Infection with encapsulated bacteria can be prevented by vaccination with capsular polysaccharides, either plain or conjugated to a protein carrier. However, results concerning these vaccinations raise several paradoxes. Polysaccharides from encapsulated bacteria are generally considered to be T cell-independent antigens which are unable to trigger a T cell-dependent germinal center reaction, but, strikingly, anti-polysaccharide antibodies are often mutated in humans. Polysaccharide–protein conjugate vaccines are able to induce a true T cell-dependent memory response with a rise in antibody titers and a switch to high-affinity IgG antibodies in children below two years of age, but neither the plain nor the conjugated vaccine can induce memory in older infants and adults. We propose some explanations for these paradoxes based on our recent observation that humans display a circulating splenic marginal zone B-cell population with a pre-diversified immunoglobulin repertoire in charge of the immune response to T cell-independent antigens.
Document type :
Journal articles
Complete list of metadata
Contributor : Sandra Weller <>
Submitted on : Wednesday, November 5, 2008 - 5:47:28 PM
Last modification on : Friday, March 27, 2020 - 2:41:53 AM
Long-term archiving on: : Tuesday, October 9, 2012 - 3:01:59 PM


Files produced by the author(s)




Sandra Weller, Claude-Agnès Reynaud, Jean-Claude Weill. Vaccination against encapsulated bacteria in humans: paradoxes.. Trends in Immunology, Elsevier, 2005, 26 (2), pp.85-9. ⟨10.1016/⟩. ⟨inserm-00337048⟩



Record views


Files downloads